EGFR and head and neck squamous cell carcinoma: Although our mRNA methodology could not screen for these biomarkers, Agulnik et al. found excess EGFR gene copy numbers in only 4 out of 37 patients, and Willmore-Payne et al. reported HER1/2 mutations in less than 10% of patients with HNSCC [23, 24].